Antioxidants Treat Smith-Lemli-Opitz Syndrome

News   Feb 05, 2018 | By Ellen Goldbaum for University at Buffalo

 
Evidenced-Based Antioxidant Therapy Prevents Vision Loss Caused by Smith-Lemli-Opitz Syndrome

Light microscopy images of retinas from animal model of Smith-Lemli-Opitz Syndrome (SLOS). Treatment with antioxidant combination therapy (right) preserved normal retinal structure and prevented degeneration and death of photoreceptor cells (rods and cones). Credit: Steven Fliesler

 
 
 

RELATED ARTICLES

People with Schizophrenia Account for More than 1 in 10 Suicide Cases

News

Suicide risk assessments early in the course of illness should be emphasized, researchers say.

READ MORE

Alzheimer’s Breakthrough: Brain Metals that May Drive Disease Progression Revealed

News

Understanding the impact and management of these metals could lead to more effective future therapies for Alzheimer’s.

READ MORE

Watching Stem Cells Repair Spinal Cord in Real Time

News

Clues to the reversal of brain and spine injury.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy